MENU
+Compare
BMEA
Stock ticker: NASDAQ
AS OF
May 21, 04:59 PM (EDT)
Price
$1.44
Change
-$0.14 (-8.92%)
Capitalization
58.99M

BMEA Biomea Fusion Forecast, Technical & Fundamental Analysis

Biomea Fusion Inc is a clinical-stage diabetes and obesity medicines company focused on the discovery and development of oral covalent small-molecule drugs to treat patients with metabolic diseases... Show more

BMEA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for BMEA with price predictions
May 20, 2025

Momentum Indicator for BMEA turns negative, indicating new downward trend

BMEA saw its Momentum Indicator move below the 0 level on May 06, 2025. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 66 similar instances where the indicator turned negative. In of the 66 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for BMEA turned negative on May 08, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 39 similar instances when the indicator turned negative. In of the 39 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BMEA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

BMEA broke above its upper Bollinger Band on April 24, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where BMEA's RSI Indicator exited the oversold zone, of 39 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 9 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BMEA advanced for three days, in of 216 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.053) is normal, around the industry mean (16.516). P/E Ratio (0.000) is within average values for comparable stocks, (60.627). BMEA's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.210). Dividend Yield (0.000) settles around the average of (0.024) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (283.856).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. BMEA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BMEA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
BMEA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

BMEA is expected to report earnings to fall 35.41% to -51 cents per share on August 04

Biomea Fusion BMEA Stock Earnings Reports
Q2'25
Est.
$-0.52
Q1'25
Beat
by $0.12
Q4'24
Beat
by $0.10
Q3'24
Beat
by $0.03
Q2'24
Beat
by $0.05
The last earnings report on May 05 showed earnings per share of -80 cents, beating the estimate of -91 cents. With 513.11K shares outstanding, the current market capitalization sits at 58.99M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
900 Middlefield Road
Phone
+1 650 980-9099
Employees
103
Web
https://www.biomeafusion.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BHVN16.250.50
+3.17%
Biohaven Ltd
VOYA69.12-0.21
-0.30%
Voya Financial
CB291.96-2.62
-0.89%
Chubb Limited
PRTA7.29-0.11
-1.49%
Prothena Corp
OPXS8.25-0.28
-3.25%
Optex Systems Holdings

BMEA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, BMEA has been loosely correlated with ARCT. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if BMEA jumps, then ARCT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BMEA
1D Price
Change %
BMEA100%
+3.97%
ARCT - BMEA
52%
Loosely correlated
+5.92%
IDYA - BMEA
35%
Loosely correlated
+8.57%
CRSP - BMEA
32%
Poorly correlated
+1.47%
PRME - BMEA
32%
Poorly correlated
-11.99%
BAIVF - BMEA
32%
Poorly correlated
N/A
More